# A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers

> **NCT00990756** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-03526299
- **DRUG:** PF-03526299

## Key facts

- **NCT ID:** NCT00990756
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990756, "A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00990756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*